Allogene Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Allogene Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $135k | 42k | 3.21 |
| 2023-09-30 | $133k | 42k | 3.17 |
| 2023-06-30 | $209k | 42k | 4.97 |
| 2023-03-31 | $208k | 42k | 4.94 |
| 2022-12-31 | $264k | 42k | 6.29 |
| 2022-09-30 | $454k | 42k | 10.80 |
| 2022-06-30 | $460k | 40k | 11.40 |
| 2022-03-31 | $331k | 36k | 9.11 |
| 2021-12-31 | $342k | 23k | 14.92 |
| 2021-09-30 | $589k | 23k | 25.71 |
| 2021-06-30 | $597k | 23k | 26.06 |
| 2021-03-31 | $809k | 23k | 35.30 |
| 2020-12-31 | $578k | 23k | 25.24 |
| 2020-09-30 | $864k | 23k | 37.72 |
| 2020-06-30 | $923k | 22k | 42.82 |
| 2020-03-31 | $350k | 18k | 19.43 |
| 2019-12-31 | $468k | 18k | 25.99 |
| 2019-09-30 | $491k | 18k | 27.26 |
| 2019-06-30 | $339k | 13k | 26.83 |
| 2019-03-31 | $365k | 13k | 28.91 |
| 2018-12-31 | $340k | 13k | 26.93 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors